AFT Pharmaceuticals Limited (NZE:AFT)
3.980
+0.050 (1.27%)
Jun 2, 2026, 11:03 AM NZST
AFT Pharmaceuticals Balance Sheet
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 10.24 | 11.11 | 12.04 | 4.75 | 7.94 |
Cash & Short-Term Investments | 10.24 | 11.11 | 12.04 | 4.75 | 7.94 |
Cash Growth | -7.83% | -7.72% | 153.53% | -40.19% | 147.43% |
Accounts Receivable | 58.13 | 43.2 | 41.01 | 39.62 | 29.87 |
Receivables | 58.13 | 43.2 | 41.01 | 39.62 | 29.87 |
Inventory | 74.07 | 48.48 | 49.06 | 42.4 | 33.5 |
Prepaid Expenses | 6.11 | 5.37 | 3.22 | 7.1 | 6.14 |
Other Current Assets | - | 0.19 | 0.41 | 0.74 | 0.1 |
Total Current Assets | 148.54 | 108.34 | 105.73 | 94.6 | 77.54 |
Property, Plant & Equipment | 3.36 | 3.25 | 3.82 | 3.37 | 3.36 |
Other Intangible Assets | 17.58 | 17.26 | 14.45 | 16.17 | 15.99 |
Long-Term Deferred Tax Assets | 0.8 | - | 2.25 | 4.47 | 8.33 |
Long-Term Deferred Charges | 46.72 | 40.97 | 39.01 | 29.46 | 22.11 |
Total Assets | 217.01 | 169.82 | 165.26 | 148.06 | 127.32 |
Accounts Payable | 29.59 | 25.12 | 25.33 | 22.19 | 12.07 |
Accrued Expenses | 11.89 | 9.8 | 11.85 | 9.57 | 8.11 |
Short-Term Debt | 11.58 | 1.08 | - | 1.46 | - |
Current Portion of Long-Term Debt | - | - | - | 1 | 4 |
Current Portion of Leases | 0.94 | 0.73 | 0.8 | 0.57 | 0.54 |
Current Income Taxes Payable | 7.04 | 2.68 | 3.8 | 0.83 | 0.84 |
Other Current Liabilities | 5.31 | 3.86 | 4.29 | 4.16 | 3.48 |
Total Current Liabilities | 66.35 | 43.26 | 46.07 | 39.78 | 29.05 |
Long-Term Debt | 39 | 25.6 | 28.2 | 32.2 | 33.2 |
Long-Term Leases | 2.59 | 2.59 | 3.19 | 2.82 | 2.77 |
Long-Term Deferred Tax Liabilities | - | 1.3 | - | - | - |
Total Liabilities | 107.94 | 72.74 | 77.46 | 74.8 | 65.02 |
Common Stock | 78.24 | 78.24 | 78.24 | 78.24 | 80.77 |
Retained Earnings | 32.38 | 19.54 | 9.26 | -5.2 | -15.85 |
Comprehensive Income & Other | -0.34 | -0.14 | 0.3 | 0.23 | -2.61 |
Total Common Equity | 110.28 | 97.64 | 87.8 | 73.27 | 62.31 |
Minority Interest | -1.21 | -0.56 | - | - | - |
Shareholders' Equity | 109.07 | 97.08 | 87.8 | 73.27 | 62.31 |
Total Liabilities & Equity | 217.01 | 169.82 | 165.26 | 148.06 | 127.32 |
Total Debt | 54.11 | 30 | 32.19 | 38.05 | 40.51 |
Net Cash (Debt) | -43.87 | -18.89 | -20.15 | -33.3 | -32.57 |
Net Cash Per Share | -0.42 | -0.18 | -0.19 | -0.32 | -0.31 |
Filing Date Shares Outstanding | 104.87 | 104.87 | 104.87 | 104.87 | 104.71 |
Total Common Shares Outstanding | 104.87 | 104.87 | 104.87 | 104.87 | 104.7 |
Working Capital | 82.2 | 65.09 | 59.66 | 54.83 | 48.49 |
Book Value Per Share | 1.05 | 0.93 | 0.84 | 0.70 | 0.60 |
Tangible Book Value | 92.7 | 80.38 | 73.34 | 57.1 | 46.32 |
Tangible Book Value Per Share | 0.88 | 0.77 | 0.70 | 0.54 | 0.44 |
Machinery | 2.59 | 2.43 | 2.15 | 2.02 | 2.05 |